Why Roswell Park for Multiple Myeloma?

Our world-class center

Roswell Park is a comprehensive cancer center designated by the National Cancer Institute, one of a select group that meet rigorous standards for quality cancer care, pioneering research and educational missions, and the only one in the state outside of New York City.

Our cutting-edge therapies

We offer treatments at the forefront of cancer care, plus clinicians with the knowledge and experience to use them. Our patients with multiple myeloma may opt for a treatment plan that includes:

  • The first chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma, which harvests cancer-killing T-cells from the patient, multiplies them in a laboratory and infuses them back into the patient to fight the cancer. Roswell Park is the only facility certified to treat patients with this latest option, Abecma™, in the region.
  • Clinical trials of the latest treatments that may not be available elsewhere, including immunotherapies and the SurVaxM vaccine, which was developed by our own researchers.

Quality, Comprehensive cancer care

Although multiple myeloma is a rare disease, Roswell Park’s experts see it every day. We provide multidisciplinary cancer care that integrates the expertise from hematologists, oncologists, hematopathologists and physicians who focus exclusively on patients with blood cell cancers like multiple myeloma.

  • Studies show that patients who are treated at high-volume, academic, comprehensive cancer centers like Roswell Park experience superior overall survival compared with those treated at other types of institutions.
  • Our broad range of support services helps to care for you, not just your cancer, including nutrition services, physical therapy, tobacco cessation, pain management, acupuncture, spiritual care, counseling, music, art and pet therapy, and more.

Request an Appointment